Search
for
Sort by
Research 121–150 of 150
- Embolic Stroke as the Initial Manifestation of Systemic Lupus Erythematosus
- Life threatening macrophage activation syndrome as the initial presentation of systemic lupus erythematosus: A case report and review of the literature
- Pericardial, pleural effusion and anasarca: A rare complication of low-dose oral minoxidil for hair loss
- Comparison of Ischemia-modified Albumin and Exercise Stress Test in Stable Angina Pectoris
- Orthostatic symptoms in women treated with low-dose oral minoxidil in the absence of overt hypotension: Implications for clinical practice
- Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis
- The Multifaceted Functions of TRPV4 and Calcium Oscillations in Tissue Repair
- Deficient anterior pituitary with common variable immune deficiency (DAVID syndrome): a new case and literature reports
- Pharmacological Strategies for Mitigating Cytarabine-Induced Multi-Organ Toxicity: A Scoping Review on Mechanisms, Efficacy and Clinical Implications
- Systemic Lupus Erythematosus: What Every Clinician Needs to Know
- Management of long COVID-19 in children and adolescents: from diagnosis to therapeutically approaches
- Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data
- The X Factor in Immunity: Sex Differences Shaped by the X Chromosome
- Unraveling Translational Insights into Systemic Multi-Organ Toxicity of Cytosine Arabinoside (Ara-C): A Systematic Review of Preclinical Animal Evidence
- Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations
- Severe Acute SARS-CoV-2 Infection and Long COVID: What Do We Know So Far? New Challenges in Diagnosis and Management
- Cardiac tamponade due to minoxidil use: a case report and review of the literature
- The Requirement to Monitor Low-dose Oral Minoxidil in the Management of Hair Loss
- Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review
- Drug History and SLE Laboratory Findings Among Iraqi Patients: A Hospital‐Based Study
- Updates in Treatment for Androgenetic Alopecia
- Repurposed Drugs: Current Trends in Drug Discovery
- Low‐Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System (FAERS) With a Focus on Pericardial Effusions
- Evaluation of the Safety and Effectiveness of Oral Minoxidil in Children: A Systematic Review
- Research progress of post-acute sequelae after SARS-CoV-2 infection
- Role of oral minoxidil in the treatment of androgenetic alopecia
- Schmallenberg virus infection suspected in a calf born to an imported heifer
- PROLACTIN AND HYPERPROLACTINAEMIA IN FEMALE REPRODUCTIVE ENDOCRINOLOGY – AN UPDATE
- Skin Manifestations of Rheumatological Diseases
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)